Artorn Anuduang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Artorn Anuduang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Kongsak Boonyapranai
School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
10 shared publications - Sakaewan Ounjaijean
School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
10 shared publications - Oranit Kraseasintra
Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand
4 shared publications - Seng Joe Lim
Department of Food Sciences, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, UKM, Bangi 43600, Selangor, Malaysia
4 shared publications Somchai Jomduang
4 shared publications- Jiraporn Laoung-On
Research Institute for Health Sciences (RIHES), Chiang Mai University, Chiang Mai 50200, Thailand
3 shared publications
Latest Publications
- Open Access
Designing Clean-Label Low-Glycemic Foods: From Starch Structure to Human Glycemic Response
Clean-label strategies to lower the glycemic impact of starch-based foods are attracting growing interest, but supporting evidence remains fragmented across starch science, food engineering, digestion methodology, and clinical nutrition. This narrative review, informed by a structured literature search, integrates this evidence into a bottom–up framework linking raw material selection, physical processing, food matrix interactions, in vitro digestion, and human glycemic testing. Using pigmented rice as a model system, it examines how heat–moisture treatment, annealing, ultrasound, extrusion, microwave-assisted processing, and controlled retrogradation reorganize starch, and how hydrocolloids, proteins, lipids, and phenolic compounds reduce enzyme accessibility or enzyme activity. This review makes three contributions. First, mechanistic claims are graded as directly demonstrated, inferred from digestibility data, or hypothetical, and D-allulose–protein conjugation is explicitly treated as a hypothesis. Second, Englyst fractions, INFOGEST kinetics, hydrolysis index, estimated GI, and ISO 26642 human GI are compared as non-interchangeable outputs. Third, an implementation table specifies, for each tier, the design variable, analytical method, evidence required, and principal limitation. The framework is a decision support tool rather than a validated predictive model; formal low-GI claims require human testing, and applications such as 3D-printed foods for older adults require separate validation.
Open AccessDesigning Clean-Label Low-Glycemic Foods: From Starch Structure to Human Glycemic Response
Clean-label strategies to lower the glycemic impact of starch-based foods are attracting growing interest, but supporting evidence remains fragmented across starch science, food engineering, digestion methodology, and clinical nutrition. This narrative review, informed by a structured literature search, integrates this evidence into a bottom–up framework linking raw material selection, physical processing, food matrix interactions, in vitro digestion, and human glycemic testing. Using pigmented rice as a model system, it examines how heat–moisture treatment, annealing, ultrasound, extrusion, microwave-assisted processing, and controlled retrogradation reorganize starch, and how hydrocolloids, proteins, lipids, and phenolic compounds reduce enzyme accessibility or enzyme activity. This review makes three contributions. First, mechanistic claims are graded as directly demonstrated, inferred from digestibility data, or hypothetical, and D-allulose–protein conjugation is explicitly treated as a hypothesis. Second, Englyst fractions, INFOGEST kinetics, hydrolysis index, estimated GI, and ISO 26642 human GI are compared as non-interchangeable outputs. Third, an implementation table specifies, for each tier, the design variable, analytical method, evidence required, and principal limitation. The framework is a decision support tool rather than a validated predictive model; formal low-GI claims require human testing, and applications such as 3D-printed foods for older adults require separate validation.
- Open Access
Emerging Oxidative, Metabolic, and Inflammatory States Associated with Working in Charcoal-Grill Shops: An Exploratory Study
Cooking with dirty fuels has been associated with an increased risk of malignancies and respiratory illnesses in kitchen and/or restaurant workers, but research on the potential oxidative stress, metabolic, and inflammatory disease risks is lagging in this demographic. Therefore, this paper addresses this gap by assessing the risk of these disease states among grill shop workers in Chiang Mai, Thailand. We used a cross-sectional design, comparing grill shop workers with controls from occupations unrelated to cooking or grilling. We measured fasting blood glucose (FBG), fasting insulin, cholesterol levels, and other metabolic parameters. Oxidative stress was measured by plasma malondialdehyde (MDA) and Trolox Equivalent Antioxidant Capacity (TEAC), while Interleukin-6 (IL-6) and high-sensitivity C-reactive Protein (hsCRP) assessed inflammatory states. Grill shop workers had higher levels of FBG [103.00 (IQR:99.00–111.75)] vs. controls [98.00 (IQR:95.25–100.00)] mg/dL; nominal p = 0.001. Also, the workers had higher MDA [1.65 (IQR:1.27–2.32)] vs. controls [0.93 (IQR:0.808–1.410) μmol/L; nominal p = 0.002]. In regression analysis, working in charcoal-grill shops was associated with elevated FBG, triglycerides, MDA, and lower hsCRP (nominal p < 0.05). Nevertheless, since these results are exploratory, longitudinal studies are required to confirm them.
Open AccessEmerging Oxidative, Metabolic, and Inflammatory States Associated with Working in Charcoal-Grill Shops: An Exploratory Study
Cooking with dirty fuels has been associated with an increased risk of malignancies and respiratory illnesses in kitchen and/or restaurant workers, but research on the potential oxidative stress, metabolic, and inflammatory disease risks is lagging in this demographic. Therefore, this paper addresses this gap by assessing the risk of these disease states among grill shop workers in Chiang Mai, Thailand. We used a cross-sectional design, comparing grill shop workers with controls from occupations unrelated to cooking or grilling. We measured fasting blood glucose (FBG), fasting insulin, cholesterol levels, and other metabolic parameters. Oxidative stress was measured by plasma malondialdehyde (MDA) and Trolox Equivalent Antioxidant Capacity (TEAC), while Interleukin-6 (IL-6) and high-sensitivity C-reactive Protein (hsCRP) assessed inflammatory states. Grill shop workers had higher levels of FBG [103.00 (IQR:99.00–111.75)] vs. controls [98.00 (IQR:95.25–100.00)] mg/dL; nominal p = 0.001. Also, the workers had higher MDA [1.65 (IQR:1.27–2.32)] vs. controls [0.93 (IQR:0.808–1.410) μmol/L; nominal p = 0.002]. In regression analysis, working in charcoal-grill shops was associated with elevated FBG, triglycerides, MDA, and lower hsCRP (nominal p < 0.05). Nevertheless, since these results are exploratory, longitudinal studies are required to confirm them.
- Open Access
Comparable Metabolic and Histopathological Observations of Enzymatic and Non-Enzymatic Thai Shallot Extracts in High-Fat Diet-Induced Obese Mice
Thai shallot (Allium cepa L. var. aggregatum) is rich in quercetin glycosides, which can be enzymatically hydrolyzed into aglycone forms with potentially higher bioavailability. However, whether this structural modification enhances metabolic efficacy in vivo remains unclear. This study aimed to compare the metabolic and histopathological effects of enzymatic (ESE) and non-enzymatic (NES) Thai shallot extracts in a high-fat diet (HFD)-induced obese mouse model. Male C57BL/6 mice were fed HFD for 12 weeks to induce obesity, followed by a 12-week treatment with NES or ESE (1000 and 2000 mg/kg/day). Metabolic parameters, lipid profiles, oxidative stress markers, hepatic enzyme activities, and histopathological changes were evaluated. Enzymatic hydrolysis significantly increased the proportion of quercetin aglycone without altering total quercetin content. Both NES and ESE improved fasting glucose, insulin resistance, lipid profiles, and oxidative stress markers compared with HFD controls. Histological examination showed attenuation of hepatic steatosis and preservation of tissue architecture in treated groups. However, no consistent superiority of ESE over NES was observed across metabolic or histopathological outcomes. Despite substantial modification of flavonoid composition, enzymatic processing did not enhance the measured metabolic efficacy of Thai shallot extract under the conditions tested. Because circulating quercetin and metabolite levels were not assessed, this finding should be interpreted as comparable metabolic efficacy rather than evidence of equivalent bioavailability. These findings suggest that factors beyond aglycone content may play a key role in determining biological activity, with implications for the development and cost-effectiveness of functional food products.
Open AccessComparable Metabolic and Histopathological Observations of Enzymatic and Non-Enzymatic Thai Shallot Extracts in High-Fat Diet-Induced Obese Mice
Thai shallot (Allium cepa L. var. aggregatum) is rich in quercetin glycosides, which can be enzymatically hydrolyzed into aglycone forms with potentially higher bioavailability. However, whether this structural modification enhances metabolic efficacy in vivo remains unclear. This study aimed to compare the metabolic and histopathological effects of enzymatic (ESE) and non-enzymatic (NES) Thai shallot extracts in a high-fat diet (HFD)-induced obese mouse model. Male C57BL/6 mice were fed HFD for 12 weeks to induce obesity, followed by a 12-week treatment with NES or ESE (1000 and 2000 mg/kg/day). Metabolic parameters, lipid profiles, oxidative stress markers, hepatic enzyme activities, and histopathological changes were evaluated. Enzymatic hydrolysis significantly increased the proportion of quercetin aglycone without altering total quercetin content. Both NES and ESE improved fasting glucose, insulin resistance, lipid profiles, and oxidative stress markers compared with HFD controls. Histological examination showed attenuation of hepatic steatosis and preservation of tissue architecture in treated groups. However, no consistent superiority of ESE over NES was observed across metabolic or histopathological outcomes. Despite substantial modification of flavonoid composition, enzymatic processing did not enhance the measured metabolic efficacy of Thai shallot extract under the conditions tested. Because circulating quercetin and metabolite levels were not assessed, this finding should be interpreted as comparable metabolic efficacy rather than evidence of equivalent bioavailability. These findings suggest that factors beyond aglycone content may play a key role in determining biological activity, with implications for the development and cost-effectiveness of functional food products.
- Open Access
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Comparative phenolic composition and cellular bioactivities of longan juice concentrate and low-sugar longan juice concentrate in RAW 264.7 macrophages and SH-SY5Y cells
Longan (Dimocarpus longan Lour.) is a phenolic-rich tropical fruit. However, its broader functional application is constrained by the high sugar content of conventional products. In this study, we developed a concentrated low-sugar longan juice (CLSLJ) using yeast fermentation followed by concentration and evaluated its phytochemical profile, antioxidant capacity, and in vitro bioactivities in comparison with concentrated longan juice (CLJ). Sugar profiling confirmed that CLJ contained high total sugars (41.01 ± 0.12%, w/w), whereas CLSLJ retained only residual glucose (1.92 ± 0.11%, w/w), with fructose and sucrose undetected. High-performance liquid chromatography revealed that CLSLJ was enriched in key phenolics, including epicatechin (1,930.32 µg/mL), syringic acid (813.97 µg/mL), ellagic acid (117.7 µg/mL), and rutin (64.86 µg/mL). CLSLJ exhibited significantly higher total phenolic content and stronger antioxidant capacity than CLJ in DPPH, ABTS, and FRAP assays (p < 0.05). In LPS-stimulated RAW 264.7 macrophages, CLSLJ dose-dependently suppressed nitric oxide production and reduced pro-inflammatory cytokines (IL-6 and TNF-α), indicating greater anti-inflammatory effects than CLJ at higher concentrations. In SH-SY5Y neuronal cells, CLSLJ attenuated H2O2-induced oxidative stress by decreasing intracellular ROS accumulation. Collectively, these results indicate that fermentation-based sugar reduction is associated with phenolic enrichment and improved cellular anti-inflammatory and oxidative-stress protective effects in vitro. CLSLJ may therefore serve as a promising functional ingredient for sugar-reduced, polyphenol-rich beverage development, warranting further validation in advanced biological models.
- 20 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessComparative phenolic composition and cellular bioactivities of longan juice concentrate and low-sugar longan juice concentrate in RAW 264.7 macrophages and SH-SY5Y cells
Longan (Dimocarpus longan Lour.) is a phenolic-rich tropical fruit. However, its broader functional application is constrained by the high sugar content of conventional products. In this study, we developed a concentrated low-sugar longan juice (CLSLJ) using yeast fermentation followed by concentration and evaluated its phytochemical profile, antioxidant capacity, and in vitro bioactivities in comparison with concentrated longan juice (CLJ). Sugar profiling confirmed that CLJ contained high total sugars (41.01 ± 0.12%, w/w), whereas CLSLJ retained only residual glucose (1.92 ± 0.11%, w/w), with fructose and sucrose undetected. High-performance liquid chromatography revealed that CLSLJ was enriched in key phenolics, including epicatechin (1,930.32 µg/mL), syringic acid (813.97 µg/mL), ellagic acid (117.7 µg/mL), and rutin (64.86 µg/mL). CLSLJ exhibited significantly higher total phenolic content and stronger antioxidant capacity than CLJ in DPPH, ABTS, and FRAP assays (p < 0.05). In LPS-stimulated RAW 264.7 macrophages, CLSLJ dose-dependently suppressed nitric oxide production and reduced pro-inflammatory cytokines (IL-6 and TNF-α), indicating greater anti-inflammatory effects than CLJ at higher concentrations. In SH-SY5Y neuronal cells, CLSLJ attenuated H2O2-induced oxidative stress by decreasing intracellular ROS accumulation. Collectively, these results indicate that fermentation-based sugar reduction is associated with phenolic enrichment and improved cellular anti-inflammatory and oxidative-stress protective effects in vitro. CLSLJ may therefore serve as a promising functional ingredient for sugar-reduced, polyphenol-rich beverage development, warranting further validation in advanced biological models.
- Open Access
The Nutritional, ACE Inhibition, and Antioxidant Properties of Hydrolysate Powders Derived from Different Stages of Thai Silkworm (Bombyx mori)
This study evaluated the bioactive potential of Thai silkworms (Bombyx mori) at three developmental stages—mature silkworm (MS), A-silking silkworm (AS), and pupae (PP)—as alternative protein sources for functional hydrolysates. Silkworm powders were hydrolyzed with Alcalase® (5% w/w, 1 h, 60 °C) to obtain MS hydrolysate powder (MSHP), AS hydrolysate powder (ASHP), and PP hydrolysate powder (PPHP). AS contained the highest protein content (72.13%), followed by MS (70.20%) and PP (56.70%). Amino acid profiling revealed stage-specific and hydrolysis-dependent variations, MS was enriched in phenylalanine and histidine, AS in threonine, valine, and tyrosine, and PP in lysine, leucine, and arginine. Hydrolysates showed markedly increased amino acid levels across all samples, indicating enhanced peptide release and improved nutritional quality. The hydrolysates achieved yields of 61–64% and protein recoveries of approximately 46%. MSHP and ASHP exhibited higher degrees of hydrolysis than PPHP. Among the biological activities, MSHP demonstrated the strongest angiotensin-converting enzyme (ACE) inhibition (88.46%), whereas PPHP exhibited the greatest antioxidant capacity (DPPH, ABTS, FRAP). Overall, Alcalase® hydrolysis effectively enhanced silkworm bioactivity, supporting their potential as multifunctional ingredients for functional foods and nutraceuticals targeting cardiovascular and oxidative stress-related disorders.
Open AccessThe Nutritional, ACE Inhibition, and Antioxidant Properties of Hydrolysate Powders Derived from Different Stages of Thai Silkworm (Bombyx mori)
This study evaluated the bioactive potential of Thai silkworms (Bombyx mori) at three developmental stages—mature silkworm (MS), A-silking silkworm (AS), and pupae (PP)—as alternative protein sources for functional hydrolysates. Silkworm powders were hydrolyzed with Alcalase® (5% w/w, 1 h, 60 °C) to obtain MS hydrolysate powder (MSHP), AS hydrolysate powder (ASHP), and PP hydrolysate powder (PPHP). AS contained the highest protein content (72.13%), followed by MS (70.20%) and PP (56.70%). Amino acid profiling revealed stage-specific and hydrolysis-dependent variations, MS was enriched in phenylalanine and histidine, AS in threonine, valine, and tyrosine, and PP in lysine, leucine, and arginine. Hydrolysates showed markedly increased amino acid levels across all samples, indicating enhanced peptide release and improved nutritional quality. The hydrolysates achieved yields of 61–64% and protein recoveries of approximately 46%. MSHP and ASHP exhibited higher degrees of hydrolysis than PPHP. Among the biological activities, MSHP demonstrated the strongest angiotensin-converting enzyme (ACE) inhibition (88.46%), whereas PPHP exhibited the greatest antioxidant capacity (DPPH, ABTS, FRAP). Overall, Alcalase® hydrolysis effectively enhanced silkworm bioactivity, supporting their potential as multifunctional ingredients for functional foods and nutraceuticals targeting cardiovascular and oxidative stress-related disorders.
- Open Access
Anti-Diabetic and Antioxidant Effect Evaluation of Thai Shallot and Cha-Miang in Diabetic Rats
Background: Type 2 diabetes mellitus is a chronic metabolic disease related to obesity and high-calorie diets, which presents hyperglycemia and insulin resistance. The management of diabetes can cause a rise in financial burden and synthetic medications can have adverse effects. This study aims to investigate the anti-diabetic and antioxidant activity of SHE, CME, and SHE in diabetic rats. Methods: Seventy-eight rats were randomly assigned to the following 13 groups (n = 6): N-DW, D-DW, D-M, D-S, D-C, D-F, D-SC, D-SF, D-SM, D-CM, D-FM, D-SCM, and D-SFM, for 8 weeks. Body weight, relative organ weight, blood glucose, insulin resistance, and plasma biomarkers related to diabetes were determined. Results: Diabetic rats had a significantly decreased body weight, RBC-GHS, liver-GHS, and RBC-SOD activity and a significantly increased relative organ weight, blood glucose levels, insulin levels, insulin resistance, HbA1C, TC, TG, LDL, plasma-MDA, and liver-MDA when compared to the N-DW group. However, plant supplementation and metformin improved diabetes-related parameters, especially the combination of CME or FCME with SHE and metformin, which showed the greatest potential for improving diabetic conditions. (4) Conclusions: The research indicates that CME or FCME conjugated with SHE and metformin demonstrates the greatest potential for enhancing diabetic conditions, confirming positive synergism. These findings suggest that the combination of CME or FCME with SHE and metformin may be effective for diabetic treatment.
Open AccessAnti-Diabetic and Antioxidant Effect Evaluation of Thai Shallot and Cha-Miang in Diabetic Rats
Background: Type 2 diabetes mellitus is a chronic metabolic disease related to obesity and high-calorie diets, which presents hyperglycemia and insulin resistance. The management of diabetes can cause a rise in financial burden and synthetic medications can have adverse effects. This study aims to investigate the anti-diabetic and antioxidant activity of SHE, CME, and SHE in diabetic rats. Methods: Seventy-eight rats were randomly assigned to the following 13 groups (n = 6): N-DW, D-DW, D-M, D-S, D-C, D-F, D-SC, D-SF, D-SM, D-CM, D-FM, D-SCM, and D-SFM, for 8 weeks. Body weight, relative organ weight, blood glucose, insulin resistance, and plasma biomarkers related to diabetes were determined. Results: Diabetic rats had a significantly decreased body weight, RBC-GHS, liver-GHS, and RBC-SOD activity and a significantly increased relative organ weight, blood glucose levels, insulin levels, insulin resistance, HbA1C, TC, TG, LDL, plasma-MDA, and liver-MDA when compared to the N-DW group. However, plant supplementation and metformin improved diabetes-related parameters, especially the combination of CME or FCME with SHE and metformin, which showed the greatest potential for improving diabetic conditions. (4) Conclusions: The research indicates that CME or FCME conjugated with SHE and metformin demonstrates the greatest potential for enhancing diabetic conditions, confirming positive synergism. These findings suggest that the combination of CME or FCME with SHE and metformin may be effective for diabetic treatment.
- Open Access
Pharmacological Activity of Cha-Miang (Camellia sinensis var. assamica) in High Fat Diet-Induced Insulin-Resistant Rats
Obesity, a major global health concern, is represented by an accumulation of adipose tissue and body mass, leading to a higher incidence of non-communicable diseases (NCDs). Camellia sinensis var. assamica, known as cha-miang, contains catechin and its derivatives, which have been reported to affect several health-related concerns such as anti-cancer, anti-inflammatory, anti-hyperlipidemia, and against cardiovascular disease. The research aimed to examine the anti-obesity and insulin resistance effects of fresh cha-miang extract (CME) and fermented cha-miang extract (FCME), and to investigate the anti-obesity and anti-diabetic effects of CME and FCME in obese rats generated by a high-fat diet. The extracts demonstrated significant antioxidant potential, with CME demonstrating greater DPPH radical scavenging activity, whereas FCME excelled in ABTS radical scavenging. In the animal model, CME and FCME significantly reduced body weight, plasma insulin levels, insulin resistance, and accumulation of fat compared to the obese control group. Moreover, plasma biochemical analysis indicated that both extracts enhanced lipid profiles by reducing cholesterol, triglycerides, and LDL-cholesterol levels, while elevating HDL-cholesterol. Histological analysis revealed decreased hepatic fat accumulation, especially when extracts were concurrently treated with metformin. The research indicates that CME and FCME, especially in conjunction with metformin, have potential anti-obesity and anti-insulin resistance benefits attributed to their abundant polyphenolic content and antioxidant characteristics. This indicates that cha-miang may serve as an effective option for the management of obesity and metabolic diseases.
Open AccessPharmacological Activity of Cha-Miang (Camellia sinensis var. assamica) in High Fat Diet-Induced Insulin-Resistant Rats
Obesity, a major global health concern, is represented by an accumulation of adipose tissue and body mass, leading to a higher incidence of non-communicable diseases (NCDs). Camellia sinensis var. assamica, known as cha-miang, contains catechin and its derivatives, which have been reported to affect several health-related concerns such as anti-cancer, anti-inflammatory, anti-hyperlipidemia, and against cardiovascular disease. The research aimed to examine the anti-obesity and insulin resistance effects of fresh cha-miang extract (CME) and fermented cha-miang extract (FCME), and to investigate the anti-obesity and anti-diabetic effects of CME and FCME in obese rats generated by a high-fat diet. The extracts demonstrated significant antioxidant potential, with CME demonstrating greater DPPH radical scavenging activity, whereas FCME excelled in ABTS radical scavenging. In the animal model, CME and FCME significantly reduced body weight, plasma insulin levels, insulin resistance, and accumulation of fat compared to the obese control group. Moreover, plasma biochemical analysis indicated that both extracts enhanced lipid profiles by reducing cholesterol, triglycerides, and LDL-cholesterol levels, while elevating HDL-cholesterol. Histological analysis revealed decreased hepatic fat accumulation, especially when extracts were concurrently treated with metformin. The research indicates that CME and FCME, especially in conjunction with metformin, have potential anti-obesity and anti-insulin resistance benefits attributed to their abundant polyphenolic content and antioxidant characteristics. This indicates that cha-miang may serve as an effective option for the management of obesity and metabolic diseases.
- Open Access
Biological Activities of Soy Protein Hydrolysate Conjugated with Mannose and Allulose
The non-enzymatic conjugation of peptides through the Maillard reaction has gained attention as an effective method to enhance biological functions. This study focuses on two conjugate mixtures: crude soy protein hydrolysate (SPH) conjugated with mannose (SPHM) and crude soy protein hydrolysate conjugated with allulose (SPHA). These two mixtures were products of the Maillard reaction, also known as non-enzymatic glycation. In vitro experiments were conducted to evaluate the antioxidant, anti-pancreatic lipase, inhibition of Bovine Serum Albumin (BSA) denaturation, and anti-angiotensin converting enzyme (ACE) activities of these conjugated mixtures. The results indicate that conjugated mixtures significantly enhance the antioxidant potential demonstrated via the DPPH and FRAP assays. SPHA exhibits superior DPPH scavenging activity (280.87 ± 16.39 µg Trolox/mL) and FRAP value (38.91 ± 0.02 mg Trolox/mL). Additionally, both conjugate mixtures, at a concentration of 10 mg/mL, enhance the BSA denaturation properties, with SPHM showing slightly higher effectiveness compared to SPHA (19.78 ± 2.26% and 5.95 ± 3.89%, respectively). SPHA also shows an improvement in pancreatic lipase inhibition (29.43 ± 1.94%) when compared to the SPHM (23.34 ± 3.75%). Furthermore, both the conjugated mixtures and rare sugars exhibit ACE inhibitory properties on their own, effectively reducing ACE activity. Notably, the ACE inhibitory effects of the individual compounds and their conjugate mixtures (SPHM and SPHA) are comparable to those of positive control (Enalapril). In conclusion, SPHM and SPHA demonstrate a variety of bioactive properties, suggesting their potential use in functional foods or as ingredients in supplementary products.
Open AccessBiological Activities of Soy Protein Hydrolysate Conjugated with Mannose and Allulose
The non-enzymatic conjugation of peptides through the Maillard reaction has gained attention as an effective method to enhance biological functions. This study focuses on two conjugate mixtures: crude soy protein hydrolysate (SPH) conjugated with mannose (SPHM) and crude soy protein hydrolysate conjugated with allulose (SPHA). These two mixtures were products of the Maillard reaction, also known as non-enzymatic glycation. In vitro experiments were conducted to evaluate the antioxidant, anti-pancreatic lipase, inhibition of Bovine Serum Albumin (BSA) denaturation, and anti-angiotensin converting enzyme (ACE) activities of these conjugated mixtures. The results indicate that conjugated mixtures significantly enhance the antioxidant potential demonstrated via the DPPH and FRAP assays. SPHA exhibits superior DPPH scavenging activity (280.87 ± 16.39 µg Trolox/mL) and FRAP value (38.91 ± 0.02 mg Trolox/mL). Additionally, both conjugate mixtures, at a concentration of 10 mg/mL, enhance the BSA denaturation properties, with SPHM showing slightly higher effectiveness compared to SPHA (19.78 ± 2.26% and 5.95 ± 3.89%, respectively). SPHA also shows an improvement in pancreatic lipase inhibition (29.43 ± 1.94%) when compared to the SPHM (23.34 ± 3.75%). Furthermore, both the conjugated mixtures and rare sugars exhibit ACE inhibitory properties on their own, effectively reducing ACE activity. Notably, the ACE inhibitory effects of the individual compounds and their conjugate mixtures (SPHM and SPHA) are comparable to those of positive control (Enalapril). In conclusion, SPHM and SPHA demonstrate a variety of bioactive properties, suggesting their potential use in functional foods or as ingredients in supplementary products.
- Open Access
Evaluation of Thai Silkworm (Bombyx mori L.) Hydrolysate Powder for Blood Pressure Reduction in Hypertensive Rats
The angiotensin-I converting enzyme (ACE) plays a pivotal role in hypertension, and while ACE inhibitors are conventional in hypertension management, synthetic medications often carry undesirable side effects. This has spurred interest in alternative ACE inhibitors derived from natural sources, such as edible insects. The silkworm, recognized for its bioactive peptides with potent ACE-inhibitory properties, has emerged as a promising candidate. This study aims to evaluate the acute toxicity and assess the antihypertensive efficacy of crude mature silkworm hydrolysate powder (MSHP) obtained from mature Thai silkworms. Utilizing the commercial protease Alcalase®2.4L, MSHP was administered at various doses, including 50, 100, and 200 mg kg−1, to hypertensive rats. The investigation spans a 14-day period to observe any potential acute toxic effects. Results indicate that MSHP exhibits LD50 values equal to or exceeding 2000 mg kg−1, signifying a low level of acute toxicity. Furthermore, the effective dose for blood pressure reduction in hypertensive rats surpasses 100 mg kg−1 of rat body weight. These findings suggest that MSHP derived from Thai mature silkworms holds promise as a natural antihypertensive food source. The implications of this research extend to the development of functional foods, functional ingredients, and dietary supplements aimed at managing hypertension.
Open AccessEvaluation of Thai Silkworm (Bombyx mori L.) Hydrolysate Powder for Blood Pressure Reduction in Hypertensive Rats
The angiotensin-I converting enzyme (ACE) plays a pivotal role in hypertension, and while ACE inhibitors are conventional in hypertension management, synthetic medications often carry undesirable side effects. This has spurred interest in alternative ACE inhibitors derived from natural sources, such as edible insects. The silkworm, recognized for its bioactive peptides with potent ACE-inhibitory properties, has emerged as a promising candidate. This study aims to evaluate the acute toxicity and assess the antihypertensive efficacy of crude mature silkworm hydrolysate powder (MSHP) obtained from mature Thai silkworms. Utilizing the commercial protease Alcalase®2.4L, MSHP was administered at various doses, including 50, 100, and 200 mg kg−1, to hypertensive rats. The investigation spans a 14-day period to observe any potential acute toxic effects. Results indicate that MSHP exhibits LD50 values equal to or exceeding 2000 mg kg−1, signifying a low level of acute toxicity. Furthermore, the effective dose for blood pressure reduction in hypertensive rats surpasses 100 mg kg−1 of rat body weight. These findings suggest that MSHP derived from Thai mature silkworms holds promise as a natural antihypertensive food source. The implications of this research extend to the development of functional foods, functional ingredients, and dietary supplements aimed at managing hypertension.